Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1979 Dec;67(4):605–610. doi: 10.1111/j.1476-5381.1979.tb08707.x

Evidence for an endogenous dopamine-mediated hypothermia in the rat

B Cox, TF Lee
PMCID: PMC2043903  PMID: 519109

Abstract

1 Unilateral intrahypothalamic injection of either dopamine (10 μg) or amphetamine (10 μg) caused a fall in core temperature in the rat. Pimozide (0.5 mg/kg, i.p.) significantly reduced the hypothermic response, whereas pretreatment with phentolamine (1 mg/kg, i.p.) or methysergide (5 mg/kg, i.p.) was ineffective.

2 Systemic pretreatment with cocaine (20 mg/kg) abolished the hypothermic effect of amphetamine, but slightly enhanced the hypothermic response to dopamine.

3 Systemic pretreatment with tranylcypromine (10 mg/kg) had no significant effect on the fall in core temperature induced by either amphetamine or dopamine.

4 Intraperitoneal injection of cocaine and tranylcypromine, on their own, caused a fall in core temperature in the rat, which was significantly antagonized by either systemic or central pretreatment with pimozide. Phentolamine and methysergide failed to block the hypothermia.

5 Unilateral intrahypothalamic injection of cocaine (20 μg) or tranylcypromine (10 μg) also caused a significant fall in core temperature, which was reduced by intrahypothalamic pretreatment with pimozide (0.5 μg), but not significantly changed by pretreatment with phentolamine (25 μg) or methysergide (5 μg).

6 These results provide evidence for the presence of a dopaminergic system within the preoptic region, which mediates a lowering of core temperature in the rat.

Full text

PDF
605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amico D. J., Calne D. B., Klawans H. L. Altered hypothermic responsivness to (+)-amphetamine. J Pharm Pharmacol. 1976 Feb;28(2):154–156. doi: 10.1111/j.2042-7158.1976.tb04116.x. [DOI] [PubMed] [Google Scholar]
  2. BRODIE B. B., SPECTOR S., SHORE P. A. Interaction of monoamine oxidase inhibitors with physiological and biochemical mechanisms in brain. Ann N Y Acad Sci. 1959 Sep 17;80:609–616. doi: 10.1111/j.1749-6632.1959.tb49239.x. [DOI] [PubMed] [Google Scholar]
  3. Cox B., Kerwin R., Lee T. F. Dopamine receptors in the central thermoregulatory pathways of the rat. J Physiol. 1978 Sep;282:471–483. doi: 10.1113/jphysiol.1978.sp012476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cox B., Lee T. F. Do central dopamine receptors have a physiological role in thermoregulation? Br J Pharmacol. 1977 Sep;61(1):83–86. doi: 10.1111/j.1476-5381.1977.tb09742.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cox B., Lee T. F. Possible involvement of 5-hydroxytryptamine in dopamine-receptor-mediated hypothermia in the rat. J Pharm Pharmacol. 1979 May;31(5):352–354. doi: 10.1111/j.2042-7158.1979.tb13521.x. [DOI] [PubMed] [Google Scholar]
  6. Crow T. J., Deakin J. F. Role of tryptaminergic mechanisms in the elements of the behavioural syndrome evoked by tryptophan and a monoamine oxidase inhibitor [proceedings]. Br J Pharmacol. 1977 Mar;59(3):461P–461P. [PMC free article] [PubMed] [Google Scholar]
  7. D'Mello G., Stolerman I. P. Cocaine and amphetamine as discriminative stimuli in rats [proceedings]. Br J Pharmacol. 1977 Mar;59(3):453P–454P. [PMC free article] [PubMed] [Google Scholar]
  8. Feldberg W., Lotti V. J. Temperature responses to monoamines and an inhibitor of MAO injected into the cerebral ventricles of rats. Br J Pharmacol Chemother. 1967 Sep;31(1):152–161. doi: 10.1111/j.1476-5381.1967.tb01985.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Glowinski J., Axelrod J., Iversen L. L. Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. J Pharmacol Exp Ther. 1966 Jul;153(1):30–41. [PubMed] [Google Scholar]
  10. Patrick R. L., Barchas J. D. Potentiation by cocaine of the stimulus-induced increase in dopamine synthesis in rat brain striatal synaptosomes. Neuropharmacology. 1977 May;16(5):327–332. doi: 10.1016/0028-3908(77)90069-7. [DOI] [PubMed] [Google Scholar]
  11. Roffler-Tarlov S., Sharman D. F., Tegerdine P. 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the mouse striatum: a reflection of intra- and extra-neuronal metabolism of dopamine? Br J Pharmacol. 1971 Jul;42(3):343–351. doi: 10.1111/j.1476-5381.1971.tb07118.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rutledge C. O. The mechanisms by which amphetamine inhibits oxidative deamination of norepinephrine in brain. J Pharmacol Exp Ther. 1970 Feb;171(2):188–195. [PubMed] [Google Scholar]
  13. Summers R. J. The effect of monoamine oxidase inhibitors on the rectal temperature of the rat. J Pharm Pharmacol. 1974 May;26(5):335–343. doi: 10.1111/j.2042-7158.1974.tb09284.x. [DOI] [PubMed] [Google Scholar]
  14. Taylor K. M., Snyder S. H. Differential effects of D- and L-amphetamine on behavior and on catecholamine disposition in dopamine and norepinephrine containing neurons of rat brain. Brain Res. 1971 May 7;28(2):295–309. doi: 10.1016/0006-8993(71)90661-5. [DOI] [PubMed] [Google Scholar]
  15. Yehuda S., Wurtman R. J. Release of brain dopamine as the probable mechanism for the hypothermic effect of D-amphetamine. Nature. 1972 Dec 22;240(5382):477–478. doi: 10.1038/240477a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES